Torgerson Lance's Form 4 filing
Civeo CorpCVEO · filed Jan 4, 2022
- Accession no.
- 0000899243-22-000623
- Filed
- Jan 4, 2022, 9:02 PM ET
- Trade date
- Jan 4-Dec 31, 2021
- Filing delay
- 365 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $10.8K. It was filed 365 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Torgerson LanceCIK 0001735901 | 10% Owner |
| Torgerson TammyCIK 0001736750 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | Common Stock | SSaleDisposed | −132 | $19.50F1 | −$2,574 | 1,436,362 | Indirect | |
| Dec 31, 2021 | Common Stock | SSaleDisposed | −20 | $19.50F1 | −$390 | 448,089 | Indirect | |
| Jan 4, 2021 | Common Stock | SSaleDisposed | −348 | $19.52F3 | −$6,792.96 | 1,436,014 | Indirect | |
| Jan 4, 2021 | Common Stock | SSaleDisposed | −52 | $19.52F3 | −$1,015.04 | 448,037 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were sold in multiple trades pursuant to a 10b5-1 plan at prices ranging from $19.50 to $19.50. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.
- F3
The shares were sold in multiple trades pursuant to a 10b5-1 plan at prices ranging from $19.50 to $19.57. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.